Researchers uncovered how fatty molecules called ceramides trigger acute kidney injury by damaging the mitochondria that ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

Rilparencel, a percutaneous minimally invasive injectable product prepared from patients’ own kidney cells, is being developed to treat those with stage 3b or 4 CKD and either type 1 or type 2 ...

Povetacicept is an investigational dual BAFF and APRIL inhibitor being tested for various glomerulonephritis types in clinical trials.

A major clinical trial shows high-dose fish oil significantly reduces cardiovascular events in hemodialysis patients, ...